Tapewire

Nasdaq · USD

LMRI

Lumexa Imaging Holdings, Inc.

Export transactions ↓
Tapewire entity
4888
SEC CIK
0002071288
Parsed reports
31

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 12, 2026 16:23 UTC
Joseph MollyDirector
GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002936 · form4.xml · nonDerivative · entry 1

Joseph Molly · CIK 0001709261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,385

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:21 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002933 · form4.xml · nonDerivative · entry 1

BRODNAX BRETT · CIK 0001242772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,385

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:22 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002935 · form4.xml · nonDerivative · entry 1

EISENBERG GLENN A · CIK 0001222831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,358

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:23 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002937 · form4.xml · nonDerivative · entry 1

Karlin Bridget E · CIK 0001797157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,358

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:22 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002934 · form4.xml · nonDerivative · entry 1

Cooper Henry Lee · CIK 0001799418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,358

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:24 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002939 · form4.xml · nonDerivative · entry 1

Mittl Robert Louis Jr. · CIK 0002101243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,358

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:24 UTC GrantCommon Stock 19,358 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002938 · form4.xml · nonDerivative · entry 1

Lungren Matthew · CIK 0002100694 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,358

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 19, 2026 Filed May 21, 2026 16:20 UTC PurchaseCommon Stock 35,000 $7.25 $253,750.00
Disclosure

SEC source: 0000905148-26-002611 · form4.xml · nonDerivative · entry 1

BRODNAX BRETT · CIK 0001242772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,027

Read SEC document
May 14, 2026 Filed May 18, 2026 16:12 UTC PurchaseCommon Stock 30,000 $7.44 $223,113.00
Disclosure

SEC source: 0000905148-26-002503 · form4.xml · nonDerivative · entry 1

Cooper Henry Lee · CIK 0001799418 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Cooper Family Trust

Disclosed balance after: 30,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.32 to $7.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

F2 · ownership.nature: These shares are directly owned by Cooper Family Trust, a revocable trust of which the Reporting Person and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 22:40 UTC
Walker James Edward Jr.Principal Accounting Officer
GrantCommon Stock 12,414 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-083296 · ownership.xml · nonDerivative · entry 1

Walker James Edward Jr. · CIK 0002102971 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,346

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:50 UTC
Zulla CaitlinDirector · Chief Executive Officer
GrantCommon Stock 64,864 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004390 · form4.xml · nonDerivative · entry 2

Zulla Caitlin · CIK 0002031509 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,728

F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3]

F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:50 UTC
Zulla CaitlinDirector · Chief Executive Officer
GrantCommon Stock 64,864 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004390 · form4.xml · nonDerivative · entry 1

Zulla Caitlin · CIK 0002031509 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,864

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 17:49 UTC
Joseph MollyDirector
GrantCommon Stock 27,027 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004388 · form4.xml · nonDerivative · entry 1

Joseph Molly · CIK 0001709261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,027

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. 13,513 RSUs vested on the grant date, and the remaining RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 17:49 UTC GrantCommon Stock 27,027 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004389 · form4.xml · nonDerivative · entry 1

BRODNAX BRETT · CIK 0001242772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,027

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:49 UTC
Szeker JulieChief Legal Officer & Corp Sec
Exercise / conversionIncentive Units of Holdings LLC · Derivative 1,250,000 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004386 · form4.xml · derivative · entry 3

Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 66,182 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

F2 · security: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

F1 · derivative.exercise_price: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

F2 · derivative.exercise_price: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

F1 · derivative.exercise_date: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

F2 · derivative.exercise_date: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

F1 · derivative.expiration_date: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

F2 · derivative.expiration_date: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

F3 · derivative.underlying_shares: Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:49 UTC
Szeker JulieChief Legal Officer & Corp Sec
GrantCommon Stock 81,081 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004386 · form4.xml · nonDerivative · entry 2

Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,263

F4 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in full on December 12, 2026, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:49 UTC
Szeker JulieChief Legal Officer & Corp Sec
Exercise / conversionCommon Stock 66,182 Not disclosed Not disclosed
Disclosure

SEC source: 0000905148-25-004386 · form4.xml · nonDerivative · entry 1

Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

F2 · price: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

F3 · balance_after: Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:49 UTC
Stewart RussellChief Medical Officer
GrantCommon Stock 4,232 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004387 · form4.xml · nonDerivative · entry 2

Stewart Russell · CIK 0002101137 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,464

F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3]

F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date.

Read SEC document
December 12, 2025 Filed Dec 16, 2025 22:49 UTC
Stewart RussellChief Medical Officer
GrantCommon Stock 4,232 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004387 · form4.xml · nonDerivative · entry 1

Stewart Russell · CIK 0002101137 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,232

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Dec 30, 2025 19:01 UTC
Walker James Edward Jr.Principal Accounting Officer
GrantCommon Stock 4,932 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004502 · form4.xml · nonDerivative · entry 1

Walker James Edward Jr. · CIK 0002102971 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,932

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 12, 2025 Filed Jan 15, 2026 17:51 UTC
Martin James AnthonyChief Financial Officer
GrantCommon Stock 27,027 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-000196 · form4.xml · nonDerivative · entry 2

Martin James Anthony · CIK 0002105348 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,054

F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3]

F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date.

Read SEC document
December 12, 2025 Filed Jan 15, 2026 17:51 UTC
Martin James AnthonyChief Financial Officer
GrantCommon Stock 27,027 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-000196 · form4.xml · nonDerivative · entry 1

Martin James Anthony · CIK 0002105348 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,027

F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.